Israeli Company Creates Single Dose Marijuana Inhaler
An Israeli company called Syque Medical, has been successful in bringing a single dose cannabis inhaler to market in Israel. Their marijuana inhaler is a pocket sized selective dose drug delivery platform. Through pictures it looks like a cross between a Ventolin or asthma relief inhaler and an Advair discus inhaler.
The company has created two versions of the inhaler. The first version is for personal use and the other is for hospital use. Both inhalers utilize selective 100 microgram dosing precision, real-time thermal and flow controllers, lung interfacing, and wireless connectivity. The wireless connectivity is used in the hospital setting so that caregivers can administer doses remotely.
Syque uses preloaded cartridges. The inhaler also collects data that can be used by doctors, researchers and healthcare providers. “This new level of precision will allow patients to reach the coveted optimum balance between symptom relief and psychoactivity, regaining their quality of life.” claims Syqe.
“For doctors, the inhaler solves the problem of prescribing plants for smoking and offers a solution for patients. For the first time, they will be able to receive a precise dose of medical cannabis,” said Syqe Medical chairman Eytan Hyam.
Israel’s Ministry of Health approved the inhaler’s use a year ago. It’s been in use at Rambam Medical Center in Halifa, the first hospital in Israel to prescribe weed as “standard medical treatment”.
“The company has completed clinical trials demonstrating the inhaler’s precision and compliance with pharmaceutical standards. In addition, the medical technology of Syqe only modifies the physical structure of the plant. Thereby enabling safe, precise and measurable delivery by inhalation, Teva and Syqe said in a joint statement.”
The Israeli Health Ministry has now approved the use of the cannabis inhalers for widespread use across the country.By 2018 Israel’s medical marijuana licenses are expected to double. There are currently about 26,000 licenses medical marijuana users in the country.
“The extent of medical cannabis use for the treatment of pain and other symptoms has increased significantly in recent years,” says Elon Eisenberg, director of the Pain Research Department at Rambam Medical Center. “The development of this inhaler fulfills our greatest hopes, to be able to administer accurate and reliable doses of cannabis….[It’s] a breakthrough in cannabis treatment and the medical use of cannabis in Israel and around the world.”
The company hasn’t indicated if they have plans to bring the inhaler to other countries, including the United States.